MYO1B and head and neck squamous cell carcinoma: Myosin 1B (MYO1B) is also upregulated in HNSCC tissues as a result of miR-145-3p downregulation, and high MYO1B expression acts as an independent predictive factor for HNSCC patient survival [27].